&w=3840&q=100)
Dr Reddy's to launch obesity drug in 87 nations starting next year: CEO
The plan for launch of generic semaglutide, active ingredient of Novo's Wegovy and Ozempic, comes as drugmakers race to grab a share of the global obesity drug market which is expected to generate around $150 billion in sales by the early 2030s.
The company initially plans to launch the generic version in Canada, India, Brazil, Turkey and other emerging markets, subject to patent expiry, Israeli said at a press conference.
"U.S. and Europe will open later," he added.
Dr Reddy's has filed relevant regulatory applications in all the countries it is planning to launch the generic version in, Israeli said.
Semaglutide will go off patent in India in March next year.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
21 minutes ago
- Mint
Stock to buy: Anand Rathi predicts Apollo Micro Systems' share price to rise 25% in 3 months. Here's why
Stock to buy: Indian brokerage firm Anand Rathi Investment Services disclosed its bullish stance on Apollo Micro Systems shares, predicting a 25% upside in the upcoming three-month period. In the stock report, Anand Rathi analysts highlighted that the shares of the Aerospace and Defence equipment maker had undergone a 'significant correction' after peaking near the ₹ 221 levels. They also stated that the stock is now moving 'within its Ichimoku cloud,' aligning with the previous breakout zone. 'The stock is moving within its Ichimoku cloud, aligning with the previous breakout zone, while the 100-day Exponential Moving Average (DEMA) also corresponds closely to this area. Fibonacci retracement levels between 38.2% and 50% further indicate potential support, suggesting a base formation near the 165-175 range,' said the analysts at Anand Rathi. On the technical front, the shares' Relative Strength Index (RSI) is hovering over the 40 support mark, which likely indicates a potential stabilisation. 'Additionally, the daily Relative Strength Index (RSI) is around the crucial 40 support mark, signalling possible stabilisation,' they said. Apollo Micro Systems Ltd (APOLLO): Buy in the range of ₹ 165-175; Target Price at ₹ 210; Stop Loss at ₹ 150 (on a daily closing basis). 'Given this technical setup, investors might consider buying or accumulating shares within the 165-175 zone. The upside target is projected at 210, while a stop-loss below 150 on a daily closing basis is recommended to manage risk. This outlook highlights key support and resistance levels that traders should monitor closely before making investment decisions,' recommended Jigar Patel, Senior Manager of Equity Research at Anand Rathi Share and Stock Brokers, in the stock report. Apollo Micro Systems shares closed 0.29% higher at ₹ 172.30 after Friday's stock market session, compared to ₹ 171.80 at the previous market close. The brokerage firm released its bullish stance on the company after market operating hours last week, on 25 July 2025. Shares of the Aerospace and Defence equipment maker have given stock market investors more than 1,280% returns on their investment in the last five years and over 39% gains in the last one-year period. On a year-to-date (YTD) basis, the stock has jumped 40.87% in 2025 but are currently trading 4.7% lower in the last five market sessions on the Indian stock market. According to data collected from the BSE website, Apollo Micro Systems shares hit their 52-week high at ₹ 221.40 on 24 June 2025, while the 52-week low was at ₹ 88.10 on 23 October 2024. The shares are currently trading under their year-high levels. The company's market capitalisation (M-Cap) stood at ₹ 5,280.82 crore as of the stock market close on Friday, 27 July 2025. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
India.com
an hour ago
- India.com
No Entry For GM Crops, Says New Delhi; India-US Trade Talks Hit A Sacred Wall
New Delhi: Genetically modified (GM) crops will not be crossing India's borders anytime soon, no matter how urgently the United States knocks. As trade negotiations between New Delhi and Washington enter a crucial phase, insiders say one red line is not up for discussion. 'There are things that are not about negotiation. Some things are a matter of principle,' said a senior official close to the development. That principle, sources say, is GM corn and soy. While American negotiators have made agricultural access a central demand, pressing India for a wider entry gate for U.S. farm goods, New Delhi is not blinking, especially on GM imports. Over the years, the issue has mutated from a mere trade disagreement into a symbolic fight over sovereignty, food safety and grassroots politics. The United States Trade Representative (USTR) has repeatedly flagged India's restrictions on GM products, calling them 'non-tariff barriers'. But Indian authorities remain unmoved, largely because of the hardline stance taken by domestic groups closely aligned with the ruling establishment. Last month, the message from Sangh affiliates was if America insists on forcing GM crops into the Indian market, there may be no trade deal at all. Carried in Business Standard, that warning echoed the sentiments of influential groups such as the Bharatiya Kisan Sangh (BKS) and the Swadeshi Jagran Manch (SJM), which have long opposed agricultural concessions to Washington, particularly in sectors like dairy and GM crops. Their argument? Food security. The BKS has often warned that allowing U.S. crops into India, especially without clear labelling or transparency, could sabotage domestic farming ecosystems and compromise health safety standards. On the other hand, the SJM sees this as a direct attack on economic self-reliance. Meanwhile, the clock is ticking. U.S. officials have privately hinted at the urgency of the moment, pointing to a deadline set by President Donald Trump, who is seeking a revival of his trade agenda. Trump has marked August 1 as a red-letter day. If no interim deal is inked by then, India could be hit with reciprocal tariffs, potentially as high as 26 percent. Indian trade negotiators are not indifferent to that pressure. But according to officials involved in the process, the sixth round of talks will only happen in the second half of August after Trump's deadline expires. Any hope for a short-term resolution seems, at best, unrealistic. As one official put it, 'We are not looking at compromise in areas that touch the lives of millions.' In other words, GM corn is off the table. And perhaps, so is the deal, at least for now.
Time of India
2 hours ago
- Time of India
Iran's supreme leader Ali Khamenei accused of sleeping, getting high all day in shocking Mossad report
A shocking social media post linked to Israel's Mossad sparked international attention after making bold claims about Iran's Supreme Leader, Ayatollah Ali Khamenei. A social media account connected to Israel's national intelligence agency accused Iran's Supreme Leader, Ayatollah Ali Khamenei, of sleeping and using drugs, causing global outrage. These explosive allegations come amid growing frustration within Iran over deteriorating living conditions and government secrecy. The contentious post, written in Farsi, mocks Khamenei while highlighting Iran's escalating domestic issues, which range from a lack of electricity to water shortages and civil unrest, as per a report by Fox News. Explore courses from Top Institutes in Please select course: Select a Course Category CXO Leadership healthcare MCA Operations Management Project Management MBA Digital Marketing Management Others Healthcare Data Analytics Degree Product Management PGDM Artificial Intelligence Technology Data Science Public Policy others Finance Design Thinking Cybersecurity Data Science Skills you'll gain: Digital Strategy Development Expertise Emerging Technologies & Digital Trends Data-driven Decision Making Leadership in the Digital Age Duration: 40 Weeks Indian School of Business ISB Chief Digital Officer Starts on Jun 30, 2024 Get Details Skills you'll gain: Technology Strategy & Innovation Emerging Technologies & Digital Transformation Leadership in Technology Management Cybersecurity & Risk Management Duration: 24 Weeks Indian School of Business ISB Chief Technology Officer Starts on Jun 28, 2024 Get Details Skills you'll gain: Customer-Centricity & Brand Strategy Product Marketing, Distribution, & Analytics Digital Strategies & Innovation Skills Leadership Insights & AI Integration Expertise Duration: 10 Months IIM Kozhikode IIMK Chief Marketing and Growth Officer Starts on Apr 7, 2024 Get Details Skills you'll gain: Operations Strategy for Business Excellence Organizational Transformation Corporate Communication & Crisis Management Capstone Project Presentation Duration: 11 Months IIM Lucknow Chief Operations Officer Programme Starts on Jun 30, 2024 Get Details What exactly did the Mossad-linked account claim? by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like War Thunder - Register now for free and play against over 75 Million real Players War Thunder Play Now Undo The Mossad's Farsi account posted on X on Friday, asking, "How can a leader lead when they sleep half the day and spend the other half high on substances?" the Mossad's Farsi account wrote Friday on X. "Water, electricity, life!" "Consuming drugs and conversing with spirits are not desirable traits for someone leading a country,' the account stated. Live Events Although the Israeli intelligence agency has not formally verified the account's affiliation, the post was made by a new X account with a premium subscription that was created last month and purported to be the official Mossad spokesperson in Farsi, Iran's official language, as per a report by Fox News. Why is this causing a stir inside and outside Iran? Over the past month, the account has posted multiple times regarding Khamenei's health and the situation in Iran, including the lack of electricity, clean water, and education. "To everyone contacting us through private messages, for your own security, please ensure you are using a VPN," the bio for the account reads. The designation of the recently appointed, albeit unnamed, commander of the Khatam al-Anbiya Central Headquarters, the command center of the Iranian Armed Forces, was covered in a post on the account. The account linked to Mossad claimed to already know the name and invited Iranians to submit their guesses after Iran refused to disclose the commander's identity for his protection, according to a report by Iran's semi-official news agency, Tasnim News Agency, which is affiliated with the Islamic Revolutionary Guard Corps, as per a report by Fox News. In response, the account advised the "lucky winner" who correctly identified Ali Abdollahi Aliabadi to "contact us privately to receive your prize." Is there credibility to these explosive accusations? While the account's tone is unconventional, even sarcastic, analysts say the information it shares carries weight. Beny Sabti, a former IDF Persian-language officer and Iran researcher at Israel's Institute for National Security Studies, said, 'Some of the details this account has posted could only have come from Mossad.' If proven credible, the claims could further tarnish Khamenei's image in a country already shaken by unrest, economic strain, and a widening generational divide. ALSO READ: National chicken finger day: Here's how to get a free chicken finger this July 27 The account's aggressive claims and humorous jabs are not typical of the Mossad's public relations style, but two intelligence analysts informed Israeli news outlet JFeed that the odd Mossad-affiliated account seems genuine. It has previously been suggested that Khamenei is a drug user; in 2022, an Iranian scholar claimed that the Iranian Supreme Leader frequently takes drugs. At the time, Nour Mohamed Omara stated on a Turkish TV station connected to the Muslim Brotherhood, "Many viewers do not know this, but Khamenei himself uses drugs." "He has a special village in Balochistan, where the drugs used by the leader are produced," the scholar continued. "This village is run by the Islamic Revolutionary Guard Corps and no one is allowed in." Drug use was openly deemed "un-Islamic" by the Ayatollah following the Iranian Revolution of 1979. Death is a possible punishment for drug-related offenses. Currently, Tehran has not released a formal statement regarding the allegations; however, Iranian state media has increased its criticism of Israel's online influence operations. In the meantime, the conversation surrounding Khamenei's alleged private behavior continues to trend. FAQs What allegations did Mossad's Farsi account make about Khamenei? According to the account, Khamenei spends the majority of his time sleeping or using drugs, while Iranians struggle to meet their basic needs. Is the Mossad-linked account verified as official? The Israeli government has not confirmed it, but experts believe the information provided indicates authenticity.
